From: Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China
Demographic and clinical factors | P value | OR | 95% CI | |
---|---|---|---|---|
Education | < 0.001 | |||
I VS P | 0.060 | 0.800 | 0.634–1.010 | |
A VS P | 0.001 | 1.435 | 1.157–1.780 | |
Medical insurance | < 0.001 | |||
B VS N | 0.001 | 1.594 | 1.216–2.088 | |
E VS N | < 0.001 | 2.730 | 2.097–3.555 | |
Prior PCI | Y VS N | 0.028 | 1.260 | 1.026–1.548 |
Hypertension | Y VS N | < 0.001 | 2.373 | 1.932–2.915 |
Hyperlipidaemia | Y VS N | 0.008 | 1.274 | 1.065–1.524 |
Diabetes | Y VS N | 0.001 | 1.395 | 1.148–1.696 |
The number of types of pillsa | < 0.001 | 0.829 | 0.765–0.898 | |
Baseline OMT | Y VS N | < 0.001 | 52.868 | 38.129–73.305 |